EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:192712 - Paxlovid
| ChEBI ID | CHEBI:192712 |
| ChEBI Name | Paxlovid |
| Stars | |
| Definition | A mixture containing nirmatrelvir and ritonavir. It is co-administered in tablet form for the treatment and post-exposure prophylaxis of COVID-19. |
| Last Modified | 15 July 2022 |
| Submitter | Adnan |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | HIV protease inhibitor An inhibitor of HIV protease, an enzyme required for production of proteins needed for viral assembly. EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor An EC 3.4.22.* (cysteine endopeptidase) inhibitor that interferes with the action of SARS coronavirus main proteinase (EC 3.4.22.69). anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Paxlovid (CHEBI:192712) has part nirmatrelvir (CHEBI:170007) |
| Paxlovid (CHEBI:192712) has part ritonavir (CHEBI:45409) |
| Paxlovid (CHEBI:192712) has role anticoronaviral agent (CHEBI:149553) |
| Paxlovid (CHEBI:192712) has role EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor (CHEBI:147285) |
| Paxlovid (CHEBI:192712) has role HIV protease inhibitor (CHEBI:35660) |
| Paxlovid (CHEBI:192712) is a mixture (CHEBI:60004) |
| Synonyms | Source |
|---|---|
| nirmatrelvir and ritonavir | KEGG DRUG |
| nirmatrelvir and ritonavir mixture | ChEBI |
| nirmatrelvir mixture with ritonavir | ChEBI |
| nirmatrelvir plus ritonavir | ChEBI |
| nirmatrelvir + ritonavir | ChEBI |
| nirmatrelvir+ritonavir | ChEBI |
| Brand Name | Source |
|---|---|
| Paxlovid | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| D12269 | KEGG DRUG |
| Nirmatrelvir/ritonavir | Wikipedia |
| Citations |
|---|